• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一线医务人员在使用新冠病毒预防药物中的心理行为:一项横断面研究

Psychological Behavior of Frontline Medical Staff in the Use of Preventive Medication for COVID-19: A Cross-Sectional Study.

作者信息

Yu Xiaoyan, Li Yuxi, Tang Li, Deng Lu, Zhao Yuxin, Zhao Xianmei, Xu Huilan, Zeng Ming

机构信息

Department of Social Medicine and Health Management, Xiangya School of Public Health, Central South University, Changsha, China.

Department of Clinical Nursing, The Second Xiangya Hospital of Central South University, Changsha, China.

出版信息

Front Psychol. 2020 Sep 25;11:2104. doi: 10.3389/fpsyg.2020.02104. eCollection 2020.

DOI:10.3389/fpsyg.2020.02104
PMID:33101103
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7545108/
Abstract

PURPOSE

To understand the current pandemic, levels of anxiety in frontline staff, and whether they have been using medication to prevent COVID-19.

METHODS

Between January 10 and March 10, 2020, 290 frontline staff completed a questionnaire incorporating the Generalized Anxiety Disorder Scale 7 (GAD-7) to indicate their psychological behavior in the use of preventive medication.

RESULTS

Of those who participated in the study, 77.6% used preventive medication, with 47.5, 40.9, and 11.6% using these as part of routine preventive treatment, to fight infection after it was contracted, and after occupational exposure, respectively. There was a statistically significant relationship between the anxiety scale scores and the frequency of medication use ( < 0.05). Comparative analyses revealed that the scores of those in the group taking medication after occupational exposure (to respiratory and blood-borne pathogens) were significantly different from other groups. The proportion of participants choosing Western medicine, traditional Chinese medicine, and integrated Chinese and Western medicine was 24.4, 28.0, and 47.6%, respectively. Additionally, the relationship between the anxiety scale scores and the three types of medication was statistically significant ( < 0.05), as was the difference between Western medicine and other groups. According to Multinomial logistic regression based on the adjustment to gender, age, educational level, marital status, current workplace, and profession, participants with moderate to severe anxiety, had higher odds ( = 10.331, 95%CI:1.453-73.429) of using Western medicine than participants with no anxiety. Participants with moderate anxiety were 6.399 times more likely to use an integrated combination of traditional Chinese and Western medicine compared to those with no anxiety ( = 6.399, 95%CI:1.007-40.658). Furthermore, those with mild anxiety were 2.656 times more likely to use integrated traditional Chinese and Western medicine than those with no anxiety ( = 2.657, 95%CI:1.075-6.570). The probability that frontline medical staff with moderate anxiety took preventive medication after occupational exposure to COVID-19 was 8.066 times ( = 8.066, 95%CI:1.043-62.353) higher than that of staff without anxiety.

DISCUSSION

This study revealed that there was more anxiety among frontline medical staff who took medication after unexpected occupational exposure. There was less anxiety among those using an integrated course of Chinese and Western medicine than Western medicine alone. It was also observed that anxiety affects the types and frequency of the preventive medication taken. Frontline medical staff who suffer from anxiety are also more likely to use medication to prevent COVID-19.

摘要

目的

了解当前的疫情、一线工作人员的焦虑程度,以及他们是否使用药物预防新冠病毒。

方法

2020年1月10日至3月10日期间,290名一线工作人员完成了一份包含广泛性焦虑障碍量表7(GAD - 7)的问卷,以表明他们在使用预防药物方面的心理行为。

结果

参与研究的人员中,77.6%使用了预防药物,其中47.5%、40.9%和11.6%分别将其作为常规预防治疗的一部分、感染后对抗感染以及职业暴露后使用。焦虑量表得分与用药频率之间存在统计学显著关系(<0.05)。比较分析显示,职业暴露(于呼吸道和血源性病原体)后服药组的得分与其他组有显著差异。选择西药、中药和中西医结合药物的参与者比例分别为24.4%、28.0%和47.6%。此外,焦虑量表得分与这三种药物类型之间的关系具有统计学意义(<0.05),西药与其他组之间也存在差异。根据基于性别、年龄、教育水平、婚姻状况、当前工作场所和职业调整的多项逻辑回归分析,中度至重度焦虑的参与者使用西药的几率(=10.331,95%CI:1.453 - 73.429)高于无焦虑的参与者。中度焦虑的参与者使用中西医结合药物的可能性是无焦虑参与者的6.399倍(=6.399,95%CI:1.007 - 40.658)。此外,轻度焦虑的参与者使用中西医结合药物的可能性是无焦虑参与者的2.656倍(=2.657,95%CI:1.075 - 6.570)。中度焦虑的一线医护人员在职业暴露于新冠病毒后服用预防药物的概率比无焦虑的工作人员高8.066倍(=8.066,95%CI:1.043 - 62.353)。

讨论

本研究表明,意外职业暴露后服药的一线医护人员焦虑情绪更严重。使用中西医结合药物的人员比仅使用西药的人员焦虑程度更低。还观察到焦虑会影响预防药物使用的类型和频率。患有焦虑症的一线医护人员也更有可能使用药物预防新冠病毒。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5c2/7545108/ec9790d87392/fpsyg-11-02104-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5c2/7545108/ec9790d87392/fpsyg-11-02104-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5c2/7545108/ec9790d87392/fpsyg-11-02104-g001.jpg

相似文献

1
Psychological Behavior of Frontline Medical Staff in the Use of Preventive Medication for COVID-19: A Cross-Sectional Study.一线医务人员在使用新冠病毒预防药物中的心理行为:一项横断面研究
Front Psychol. 2020 Sep 25;11:2104. doi: 10.3389/fpsyg.2020.02104. eCollection 2020.
2
Occupational Stress and Mental Health: A Comparison Between Frontline Medical Staff and Non-frontline Medical Staff During the 2019 Novel Coronavirus Disease Outbreak.职业压力与心理健康:2019年新型冠状病毒病疫情期间一线医务人员与非一线医务人员的比较
Front Psychiatry. 2020 Dec 23;11:555703. doi: 10.3389/fpsyt.2020.555703. eCollection 2020.
3
Adverse Psychological Reactions and Psychological Aids for Medical Staff During the COVID-19 Outbreak in China.中国新冠疫情期间医护人员的不良心理反应及心理援助
Front Psychiatry. 2021 Apr 15;12:580067. doi: 10.3389/fpsyt.2021.580067. eCollection 2021.
4
The prevalence and risk factors of psychological disturbances of frontline medical staff in china under the COVID-19 epidemic: Workload should be concerned.新型冠状病毒肺炎疫情下中国一线医务人员心理障碍的发生率及相关因素:应关注工作负荷。
J Affect Disord. 2020 Dec 1;277:510-514. doi: 10.1016/j.jad.2020.08.059. Epub 2020 Aug 26.
5
Emotional State of Chinese Healthcare Workers During COVID-19 Pandemic.新冠疫情期间中国医护人员的情绪状态
Front Psychol. 2022 Mar 23;13:854815. doi: 10.3389/fpsyg.2022.854815. eCollection 2022.
6
The psychological impact of anxiety and depression on Chinese medical staff during the outbreak of the COVID-19 pandemic: a cross-sectional study.新冠疫情期间焦虑和抑郁对中国医务人员的心理影响:一项横断面研究。
Ann Palliat Med. 2021 Jul;10(7):7759-7774. doi: 10.21037/apm-21-1261.
7
The prevalence and influencing factors in anxiety in medical workers fighting COVID-19 in China: a cross-sectional survey.中国抗击 COVID-19 医务人员焦虑的患病率及其影响因素:一项横断面调查。
Epidemiol Infect. 2020 May 20;148:e98. doi: 10.1017/S0950268820001107.
8
Sex Differences in Psychological Status and Fatigue of Frontline Staff After the COVID-19 Outbreak in China: A Cross-Sectional Study.中国新冠疫情爆发后一线工作人员心理状态与疲劳的性别差异:一项横断面研究
Front Psychol. 2021 Sep 8;12:676307. doi: 10.3389/fpsyg.2021.676307. eCollection 2021.
9
Influencing Factors Associated With Mental Health Outcomes Among Dental Medical Staff in Emergency Exposed to Coronavirus Disease 2019: A Multicenter Cross-Sectional Study in China.2019年冠状病毒病应急状态下牙科医务人员心理健康结局的相关影响因素:一项中国多中心横断面研究
Front Psychiatry. 2021 Oct 25;12:736172. doi: 10.3389/fpsyt.2021.736172. eCollection 2021.
10
Analysis of Psychological Trends and Policy Recommendations of Medical Staff in Northern China in the Latter Stages of the COVID-19 Pandemic.新冠疫情后期中国北方医务人员心理趋势分析及政策建议
Front Psychol. 2021 Oct 20;12:747557. doi: 10.3389/fpsyg.2021.747557. eCollection 2021.

引用本文的文献

1
Fear of COVID-19 and COVID-19 Stress and Association with Sociodemographic and Psychological Process Factors in Cases under Surveillance in a Frontline Worker Population in Borneo.对 COVID-19 的恐惧和 COVID-19 压力,以及在婆罗洲一线工人人群中监测病例的社会人口学和心理过程因素的关联。
Int J Environ Res Public Health. 2021 Jul 5;18(13):7210. doi: 10.3390/ijerph18137210.

本文引用的文献

1
Team management in critical care units for patients with COVID-19: an experience from Hunan Province, China.新型冠状病毒肺炎(COVID-19)患者重症监护病房的团队管理:来自中国湖南省的经验
Crit Care. 2020 Jun 6;24(1):304. doi: 10.1186/s13054-020-02921-7.
2
Factors Associated With Mental Health Outcomes Among Health Care Workers Exposed to Coronavirus Disease 2019.与 COVID-19 暴露的医护人员心理健康结果相关的因素。
JAMA Netw Open. 2020 Mar 2;3(3):e203976. doi: 10.1001/jamanetworkopen.2020.3976.
3
Combination of western medicine and Chinese traditional patent medicine in treating a family case of COVID-19.
西医结合中药治疗一家新冠病例。
Front Med. 2020 Apr;14(2):210-214. doi: 10.1007/s11684-020-0757-x. Epub 2020 Mar 13.
4
Timely development of vaccines against SARS-CoV-2.针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的疫苗的及时研发。
Emerg Microbes Infect. 2020 Mar 8;9(1):542-544. doi: 10.1080/22221751.2020.1737580. eCollection 2020.
5
Traditional Chinese medicine is a resource for drug discovery against 2019 novel coronavirus (SARS-CoV-2).传统中药是针对2019新型冠状病毒(SARS-CoV-2)进行药物研发的资源。
J Integr Med. 2020 Mar;18(2):87-88. doi: 10.1016/j.joim.2020.02.004. Epub 2020 Feb 19.
6
Can Chinese Medicine Be Used for Prevention of Corona Virus Disease 2019 (COVID-19)? A Review of Historical Classics, Research Evidence and Current Prevention Programs.中医可否用于预防 2019 年冠状病毒病(COVID-19)?对历史经典、研究证据和当前预防方案的回顾。
Chin J Integr Med. 2020 Apr;26(4):243-250. doi: 10.1007/s11655-020-3192-6. Epub 2020 Feb 17.
7
Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment.四例新型冠状病毒肺炎患者采用中西医结合治疗的临床特点和治疗经过。
Biosci Trends. 2020 Mar 16;14(1):64-68. doi: 10.5582/bst.2020.01030. Epub 2020 Feb 9.
8
The mental health of medical workers in Wuhan, China dealing with the 2019 novel coronavirus.中国武汉应对2019新型冠状病毒的医护人员的心理健康状况。
Lancet Psychiatry. 2020 Mar;7(3):e14. doi: 10.1016/S2215-0366(20)30047-X. Epub 2020 Feb 5.
9
Challenge and threat states: examining cardiovascular, cognitive and affective responses to two distinct laboratory stress tasks.挑战和威胁状态:检测两种不同实验室应激任务对心血管、认知和情感的反应。
Int J Psychophysiol. 2018 Apr;126:42-51. doi: 10.1016/j.ijpsycho.2018.02.004. Epub 2018 Mar 2.
10
A brief measure for assessing generalized anxiety disorder: the GAD-7.一种评估广泛性焦虑症的简短量表:GAD-7量表。
Arch Intern Med. 2006 May 22;166(10):1092-7. doi: 10.1001/archinte.166.10.1092.